153 related articles for article (PubMed ID: 30510456)
1. Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer.
Guo LW; Jiang LM; Gong Y; Zhang HH; Li XG; He M; Sun WL; Ling H; Hu X
Cancer Manag Res; 2018; 10():5881-5894. PubMed ID: 30510456
[TBL] [Abstract][Full Text] [Related]
2. Nomograms predicting survival for all four subtypes of breast cancer: a SEER-based population study.
Chu J; Yang D; Wang L; Xia J
Ann Transl Med; 2020 Apr; 8(8):544. PubMed ID: 32411767
[TBL] [Abstract][Full Text] [Related]
3. Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age.
Cui X; Song D; Li X
Front Oncol; 2020; 10():636549. PubMed ID: 33628740
[TBL] [Abstract][Full Text] [Related]
4. Predicting Survival Benefit of Sparing Sentinel Lymph Node Biopsy in Low-Risk Elderly Patients With Early Breast Cancer: A Population-Based Analysis.
Xu L; Wen N; Qiu J; He T; Tan Q; Yang J; Du Z; Lv Q
Front Oncol; 2020; 10():1718. PubMed ID: 33042815
[No Abstract] [Full Text] [Related]
5. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
6. Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer.
Sun W; Jiang YZ; Liu YR; Ma D; Shao ZM
Oncotarget; 2016 Apr; 7(15):20496-506. PubMed ID: 26967253
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer.
Chen MS; Liu PC; Yi JZ; Xu L; He T; Wu H; Yang JQ; Lv Q
Sci Rep; 2022 Aug; 12(1):14659. PubMed ID: 36038627
[TBL] [Abstract][Full Text] [Related]
8. Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer.
Li Y; Ma L
BMC Cancer; 2021 Aug; 21(1):965. PubMed ID: 34454451
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of Nomograms for Predicting Overall and Breast Cancer-Specific Survival in Young Women with Breast Cancer: A Population-Based Study.
Gong Y; Ji P; Sun W; Jiang YZ; Hu X; Shao ZM
Transl Oncol; 2018 Dec; 11(6):1334-1342. PubMed ID: 30189361
[TBL] [Abstract][Full Text] [Related]
10. Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Nonmetastatic Inflammatory Breast Cancer Patients Receiving Tri-Modality Therapy: A Population-Based Study.
Huang Q; Xu TY; Wu ZY
Med Sci Monit; 2019 Dec; 25():9167-9178. PubMed ID: 31789307
[TBL] [Abstract][Full Text] [Related]
11. Survival outcome assessment for triple-negative breast cancer: a nomogram analysis based on integrated clinicopathological, sonographic, and mammographic characteristics.
Sheng DL; Shen XG; Shi ZT; Chang C; Li JW
Eur Radiol; 2022 Oct; 32(10):6575-6587. PubMed ID: 35759017
[TBL] [Abstract][Full Text] [Related]
12. Nomograms predict survival in elderly women with triple-negative breast cancer: A SEER population-based study.
Feng R; Huang W; Liu B; Li D; Zhao J; Yu Y; Cao X; Wang X
Technol Health Care; 2024 Jan; ():. PubMed ID: 38306071
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of nomograms for predicting overall and cancer-specific survival in young patients with non-small cell lung cancer.
Peng Y; Sun Y
J Thorac Dis; 2020 Apr; 12(4):1404-1416. PubMed ID: 32395278
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer.
Yang Y; Wang Y; Deng H; Tan C; Li Q; He Z; Wei W; Zhou E; Liu Q; Liu J
BMC Cancer; 2019 Jun; 19(1):541. PubMed ID: 31170946
[TBL] [Abstract][Full Text] [Related]
15. Nomogram Predicts the Role of Primary Tumor Surgery on
Cui H; Dai L; Bao Y; Hu L; Zhou Z; Wang M; Lin S; Wu H; Ma X; Kang H
Front Oncol; 2022; 12():819531. PubMed ID: 35600374
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a prognostic nomogram for patients with triple-negative breast cancer with histology of infiltrating duct carcinoma.
Jing N; Ma MW; Gao XS; Liu JT; Gu XB; Zhang M; Zhao B; Wang Y; Wang XL; Jia HX
Ann Transl Med; 2020 Nov; 8(21):1447. PubMed ID: 33313192
[TBL] [Abstract][Full Text] [Related]
17. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
[TBL] [Abstract][Full Text] [Related]
18. Establishment and validation of prognostic nomograms to predict overall survival and cancer-specific survival for patients with osteosarcoma.
Yang QK; Lai QY; Wang Y; Wang Y; Yao ZX; Zhang XJ
Neoplasma; 2021 Mar; 68(2):434-446. PubMed ID: 33118831
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma.
Chen Q; Wang S; Lang JH
J Ovarian Res; 2020 Oct; 13(1):123. PubMed ID: 33069259
[TBL] [Abstract][Full Text] [Related]
20. Nomogram predicting overall prognosis for invasive micropapillary carcinoma of the breast: a SEER-based population study.
Liu J; Xi W; Zhou J; Gao W; Wu Q
BMJ Open; 2023 Aug; 13(8):e072632. PubMed ID: 37550031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
